JAMES PATRINELY to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications JAMES PATRINELY has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.255
-
Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders. J Immunother Cancer. 2021 05; 9(5).
Score: 0.115
-
Outcomes after progression of disease with anti-PD-1/PD-L1 therapy for patients with advanced melanoma. Cancer. 2020 08 01; 126(15):3448-3455.
Score: 0.108
-
Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study. Eur J Cancer. 2022 11; 176:121-132.
Score: 0.032